| |
| |
|
| Insider
Information: |
Pellini Michael J |
| Relationship: |
Director |
| City: |
Wayne |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
170,699 |
|
|
Indirect Shares
|
251,933 |
|
|
| Direct
Value |
$549,531 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
422,632 |
|
|
| Total
Value |
$549,531 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -43.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Clarient Inc |
CLRT |
President and COO |
2010-12-22 |
0 |
2008-05-30 |
0 |
Premium* |
|
|
Foundation Medicine, Inc. |
FMI |
Director |
2018-07-31 |
0 |
|
0 |
Premium* |
|
|
Adaptive Biotechnologies Corp |
ADPT |
Director |
2024-03-04 |
54,296 |
2020-10-14 |
0 |
Premium* |
|
|
Singular Genomics Systems, Inc. |
OMIC |
Director |
2022-05-31 |
99,289 |
2022-05-31 |
251,933 |
Premium* |
|
|
GeneDx Holdings Corp |
WGS |
Director |
2022-10-15 |
17,114 |
2022-04-27 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
73 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FMI |
Foundation Medicine, Inc. |
Director |
– • – |
2017-12-05 |
4 |
S |
$61.47 |
$556,488 |
D/D |
(9,053) |
258,175 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Executive Officer |
• • – |
2015-11-13 |
4 |
B |
$16.43 |
$149,555 |
D/D |
9,100 |
174,025 |
2.81 |
- |
|
| FMI |
Foundation Medicine, Inc. |
President & CEO |
• • – |
2014-11-13 |
4 |
AS |
$24.93 |
$236,850 |
D/D |
(9,500) |
475,500 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Director |
– • – |
2018-01-17 |
4 |
AS |
$65.52 |
$665,028 |
D/D |
(10,150) |
148,694 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Executive Officer |
• • – |
2017-01-03 |
4 |
S |
$17.41 |
$194,052 |
D/D |
(11,146) |
326,124 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
President & CEO |
• • – |
2014-07-01 |
4 |
AS |
$27.30 |
$341,244 |
D/D |
(12,500) |
512,500 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
President & CEO |
• • – |
2014-10-17 |
4 |
AS |
$23.00 |
$287,500 |
D/D |
(12,500) |
485,000 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
President & CEO |
• • – |
2014-12-29 |
4 |
AS |
$23.91 |
$298,919 |
D/D |
(12,500) |
460,000 |
0 |
- |
|
| WGS |
GeneDx Holdings Corp |
Director |
– • – |
2022-04-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,836 |
12,836 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Director |
– • – |
2018-04-03 |
4 |
AS |
$70.28 |
$959,955 |
D/D |
(13,659) |
114,211 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Director |
– • – |
2023-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
14,775 |
22,968 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Director |
– • – |
2017-07-06 |
4 |
S |
$38.84 |
$615,847 |
D/D |
(15,856) |
305,077 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Director |
– • – |
2018-02-15 |
4 |
AS |
$67.69 |
$1,172,662 |
D/D |
(17,324) |
131,370 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
President & CEO |
• • – |
2015-02-11 |
4 |
AS |
$48.56 |
$849,853 |
D/D |
(17,500) |
420,000 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Executive Officer |
• • – |
2015-03-30 |
4 |
AS |
$48.48 |
$848,323 |
D/D |
(17,500) |
517,760 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Executive Officer |
• • – |
2015-05-12 |
4 |
AS |
$40.24 |
$704,232 |
D/D |
(17,500) |
105,560 |
0 |
- |
|
| CLRT |
Clarient Inc |
President and COO |
• – – |
2010-12-17 |
4 |
D |
$5.00 |
$100,000 |
D/D |
(20,000) |
300,000 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Director |
– • – |
2021-03-01 |
4/A |
S |
$57.80 |
$1,156,000 |
D/D |
(20,000) |
1,504 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Director |
– • – |
2021-03-01 |
4 |
OE |
$6.55 |
$131,000 |
D/D |
20,000 |
20,000 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Director |
– • – |
2021-03-01 |
4 |
S |
$57.80 |
$1,156,000 |
D/D |
(20,000) |
0 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
Director |
– • – |
2021-03-01 |
4/A |
OE |
$6.55 |
$131,000 |
D/D |
20,000 |
21,504 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Director |
– • – |
2017-12-06 |
4 |
S |
$58.11 |
$1,217,230 |
D/D |
(20,947) |
237,228 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
President & CEO |
• • – |
2015-01-12 |
4 |
AS |
$51.07 |
$1,149,147 |
D/D |
(22,500) |
437,500 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
President & CEO |
• • – |
2014-06-04 |
4 |
S |
$23.53 |
$588,155 |
D/D |
(25,000) |
525,000 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Director |
– • – |
2020-12-21 |
4 |
OE |
$6.55 |
$163,750 |
D/D |
25,000 |
25,000 |
0 |
- |
|
73 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
